ZHENJIANG QMIBABY MOTHER & BABY PRODUCT CO., LTD. – Trademark Portfolio
Entity Type: 99
ZHENJIANG QMIBABY MOTHER & BABY PRODUCT CO., LTD. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 21 (Housewares) — 2 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 1 trademark is registered and 2 are pending. Notable registered marks include COMIBABY. The owner is based in JIANGSU,.
NO. 88 GUANGMING ROAD, DANTU
INDUSTRY PARK, ZHENJIANG CITY,
JIANGSU, 212000 , CN
Showing of trademarks Trademarks
Trademark Classifications
ZHENJIANG QMIBABY MOTHER & BABY PRODUCT CO., LTD.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Frequently Asked Questions
How many trademarks does ZHENJIANG QMIBABY MOTHER & BABY PRODUCT CO., LTD. have?
ZHENJIANG QMIBABY MOTHER & BABY PRODUCT CO., LTD. has 4 U.S. trademarks filed with the USPTO. Of these, 1 registered, 2 pending, 1 cancelled.
What trademark classes does ZHENJIANG QMIBABY MOTHER & BABY PRODUCT CO., LTD. file in?
ZHENJIANG QMIBABY MOTHER & BABY PRODUCT CO., LTD. files trademarks across 2 Nice Classification classes. The most active classes are Class 21 (Housewares), Class 10 (Medical Apparatus). Class 21 covers household or kitchen utensils and containers; combs and sponges; brushes.
What are ZHENJIANG QMIBABY MOTHER & BABY PRODUCT CO., LTD.'s most well-known trademarks?
ZHENJIANG QMIBABY MOTHER & BABY PRODUCT CO., LTD.'s registered trademark portfolio includes well-known marks such as COMIBABY. These are among 1 currently registered trademark in the portfolio.
What is ZHENJIANG QMIBABY MOTHER & BABY PRODUCT CO., LTD.'s trademark registration success rate?
ZHENJIANG QMIBABY MOTHER & BABY PRODUCT CO., LTD. has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 2 applications are pending review.